|
|
|
Insider
Information: |
D Alonzo Thomas |
Relationship: |
Acting President and C... |
City: |
Raleigh |
State: |
NC |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
0 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
0 |
|
|
Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Salix Pharmaceuticals Ltd |
SLXP |
Acting President and C... |
2015-04-01 |
0 |
2015-04-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
56 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SLXP |
Salix Pharmaceuticals Ltd |
Director |
|
2006-05-08 |
4 |
B |
$13.01 |
$78,076 |
I/I |
6,000 |
6,500 |
2.1 |
- |
|
SLXP |
Salix Pharmaceuticals Ltd |
Director |
|
2006-05-08 |
4 |
B |
$13.01 |
$11,709 |
D/D |
900 |
28,900 |
2.39 |
- |
|
SLXP |
Salix Pharmaceuticals Ltd |
Director |
|
2010-10-07 |
4 |
B |
$38.00 |
$9,880 |
I/I |
260 |
260 |
2.1 |
- |
|
SLXP |
Salix Pharmaceuticals Ltd |
Director |
|
2010-12-01 |
4 |
B |
$44.80 |
$22,399 |
I/I |
500 |
500 |
2.1 |
- |
|
SLXP |
Salix Pharmaceuticals Ltd |
Director |
|
2011-08-11 |
4 |
B |
$29.77 |
$17,267 |
I/I |
580 |
1,080 |
2.1 |
- |
|
SLXP |
Salix Pharmaceuticals Ltd |
Director |
|
2011-08-11 |
4 |
B |
$29.45 |
$3,240 |
D/D |
110 |
69,340 |
2.31 |
- |
|
SLXP |
Salix Pharmaceuticals Ltd |
Director |
|
2008-07-01 |
4 |
D |
$7.03 |
$16,225 |
D/D |
(2,308) |
42,693 |
0 |
- |
|
SLXP |
Salix Pharmaceuticals Ltd |
Director |
|
2010-07-01 |
4 |
D |
$39.03 |
$118,651 |
D/D |
(3,040) |
61,320 |
0 |
- |
|
SLXP |
Salix Pharmaceuticals Ltd |
Director |
|
2011-07-01 |
4 |
D |
$39.83 |
$43,415 |
D/D |
(1,090) |
69,230 |
0 |
- |
|
SLXP |
Salix Pharmaceuticals Ltd |
Director |
|
2012-01-03 |
4 |
D |
$47.85 |
$55,506 |
D/D |
(1,160) |
78,480 |
0 |
- |
|
SLXP |
Salix Pharmaceuticals Ltd |
Director |
|
2013-06-13 |
4 |
D |
$65.04 |
$67,642 |
D/D |
(1,040) |
87,524 |
0 |
- |
|
SLXP |
Salix Pharmaceuticals Ltd |
Director |
|
2014-06-13 |
4 |
D |
$113.80 |
$163,758 |
D/D |
(1,439) |
77,740 |
0 |
- |
|
SLXP |
Salix Pharmaceuticals Ltd |
Acting President and CEO |
|
2015-04-01 |
4 |
D |
$173.00 |
$12,898,015 |
D/D |
(74,555) |
0 |
0 |
- |
|
SLXP |
Salix Pharmaceuticals Ltd |
Acting President and CEO |
|
2015-04-01 |
4 |
D |
$173.00 |
$3,638,536 |
D/D |
(21,032) |
0 |
0 |
- |
|
SLXP |
Salix Pharmaceuticals Ltd |
Acting President and CEO |
|
2015-04-01 |
4 |
D |
$173.00 |
$3,164,170 |
I/I |
(18,290) |
0 |
0 |
- |
|
SLXP |
Salix Pharmaceuticals Ltd |
Director |
|
2014-01-24 |
4 |
GA |
$0.00 |
$0 |
I/I |
10,450 |
10,450 |
0 |
- |
|
SLXP |
Salix Pharmaceuticals Ltd |
Director |
|
2014-01-24 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,450 |
87,524 |
0 |
- |
|
SLXP |
Salix Pharmaceuticals Ltd |
Director |
|
2009-05-11 |
4 |
OE |
$4.92 |
$36,900 |
D/D |
7,500 |
62,869 |
0 |
- |
|
SLXP |
Salix Pharmaceuticals Ltd |
Director |
|
2009-05-12 |
4 |
OE |
$4.92 |
$36,900 |
D/D |
7,500 |
62,869 |
0 |
- |
|
SLXP |
Salix Pharmaceuticals Ltd |
Director |
|
2009-05-13 |
4 |
OE |
$4.92 |
$36,900 |
D/D |
7,500 |
62,869 |
0 |
- |
|
SLXP |
Salix Pharmaceuticals Ltd |
Director |
|
2013-04-08 |
4 |
OE |
$7.60 |
$114,000 |
D/D |
15,000 |
90,640 |
0 |
- |
|
SLXP |
Salix Pharmaceuticals Ltd |
Director |
|
2014-01-10 |
4 |
OE |
$18.87 |
$424,575 |
D/D |
22,500 |
110,024 |
0 |
- |
|
SLXP |
Salix Pharmaceuticals Ltd |
Director |
|
2004-02-11 |
4 |
S |
$26.60 |
$106,400 |
D/D |
(4,000) |
14,000 |
|
- |
|
SLXP |
Salix Pharmaceuticals Ltd |
Director |
|
2004-02-11 |
4 |
S |
$26.50 |
$278,741 |
I/I |
(10,500) |
4,000 |
|
- |
|
SLXP |
Salix Pharmaceuticals Ltd |
Director |
|
2004-02-12 |
4 |
S |
$27.93 |
$83,790 |
I/I |
(3,000) |
3,500 |
|
- |
|
56 Records found
|
|
Page 2 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|